Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 156

1.

Surgical curability of medullary thyroid cancer in multiple endocrine neoplasia 2B: a changing perspective.

Brauckhoff M, Machens A, Lorenz K, Bjøro T, Varhaug JE, Dralle H.

Ann Surg. 2014 Apr;259(4):800-6. doi: 10.1097/SLA.0b013e3182a6f43a.

PMID:
23979292
2.

Multiple endocrine neoplasia type 2B with a RET proto-oncogene A883F mutation displays a more indolent form of medullary thyroid carcinoma compared with a RET M918T mutation.

Jasim S, Ying AK, Waguespack SG, Rich TA, Grubbs EG, Jimenez C, Hu MI, Cote G, Habra MA.

Thyroid. 2011 Feb;21(2):189-92. doi: 10.1089/thy.2010.0328. Epub 2010 Dec 27.

3.

Medullary thyroid carcinoma in children with multiple endocrine neoplasia types 2A and 2B.

Skinner MA, DeBenedetti MK, Moley JF, Norton JA, Wells SA Jr.

J Pediatr Surg. 1996 Jan;31(1):177-81; discussion 181-2.

PMID:
8632274
4.

Multiple endocrine neoplasia 2B syndrome due to codon 918 mutation: clinical manifestation and course in early and late onset disease.

Brauckhoff M, Gimm O, Weiss CL, Ukkat J, Sekulla C, Brauckhoff K, Thanh PN, Dralle H.

World J Surg. 2004 Dec;28(12):1305-11. Epub 2004 Nov 4. Review.

PMID:
15517484
5.

Very early detection of RET proto-oncogene mutation is crucial for preventive thyroidectomy in multiple endocrine neoplasia type 2 children: presence of C-cell malignant disease in asymptomatic carriers.

Sanso GE, Domene HM, Garcia R, Pusiol E, de M, Roque M, Ring A, Perinetti H, Elsner B, Iorcansky S, Barontini M.

Cancer. 2002 Jan 15;94(2):323-30.

6.

[Multiple endocrine neoplasia syndromes. Type 2].

Juodele L, Juozaityte E, Zindzius A, Pundzius J.

Medicina (Kaunas). 2005;41(4):281-94. Review. Lithuanian.

7.

Failure to recognize multiple endocrine neoplasia 2B: more common than we think?

Wray CJ, Rich TA, Waguespack SG, Lee JE, Perrier ND, Evans DB.

Ann Surg Oncol. 2008 Jan;15(1):293-301. Epub 2007 Oct 26.

PMID:
17963006
8.

Premonitory symptoms preceding metastatic medullary thyroid cancer in MEN 2B: An exploratory analysis.

Brauckhoff M, Machens A, Hess S, Lorenz K, Gimm O, Brauckhoff K, Sekulla C, Dralle H.

Surgery. 2008 Dec;144(6):1044-50; discussion 1050-3. doi: 10.1016/j.surg.2008.08.028.

PMID:
19041016
9.

Medullary thyroid carcinoma in multiple endocrine neoplasia types 2A and 2B.

O'Riordain DS, O'Brien T, Weaver AL, Gharib H, Hay ID, Grant CS, van Heerden JA.

Surgery. 1994 Dec;116(6):1017-23.

PMID:
7985081
10.

Medullary thyroid carcinoma as part of a multiple endocrine neoplasia type 2B syndrome: influence of the stage on the clinical course.

Leboulleux S, Travagli JP, Caillou B, Laplanche A, Bidart JM, Schlumberger M, Baudin E.

Cancer. 2002 Jan 1;94(1):44-50.

11.

Multiple endocrine neoplasia type 2B--genetic basis and clinical expression.

Lee NC, Norton JA.

Surg Oncol. 2000 Nov;9(3):111-8. Review.

PMID:
11356339
12.

Mutation analysis of the RET proto-oncogene and early thyroidectomy: results of a Portuguese cancer centre.

Bugalho MJ, Domingues R, Santos JR, Catarino AL, Sobrinho L.

Surgery. 2007 Jan;141(1):90-5. Epub 2006 Jul 31.

PMID:
17188172
13.

[Early diagnosis of multiple endocrine neoplasia type 2 (MEN 2) by detection of mutated RET proto-oncogene carriers].

Sansó G, Domené HM, Iorcansky S, Barontini M.

Medicina (B Aires). 1998;58(2):179-84. Spanish.

PMID:
9706252
14.

A nationwide clinical survey of patients with multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma in Japan.

Iihara M, Yamashita T, Okamoto T, Kanbe M, Yamazaki K, Egawa S, Yamaguchi K, Obara T.

Jpn J Clin Oncol. 1997 Jun;27(3):128-34.

PMID:
9255265
15.

Medullary thyroid carcinoma in a 2-month-old male with multiple endocrine neoplasia 2B and symptoms of pseudo-Hirschsprung disease: a case report.

Unruh A, Fitze G, Jänig U, Bielack S, Lochbühler H, Coerdt W.

J Pediatr Surg. 2007 Sep;42(9):1623-6.

PMID:
17848262
16.

A case of multiple endocrine neoplasia type 2B undiagnosed for many years despite its typical phenotype.

Ohyama T, Sato M, Murao K, Kittaka K, Namihira H, Matsubara S, Imachi H, Yamauchi K, Takahara J.

Endocrine. 2001 Jul;15(2):143-6.

PMID:
11720239
18.

Molecular and biochemical screening for the diagnosis and management of medullary thyroid carcinoma in multiple endocrine neoplasia type 2A.

Vieira AE, Mello MP, Elias LL, Lau IF, Maciel LM, Moreira AC, Castro M.

Horm Metab Res. 2002 Apr;34(4):202-6.

PMID:
11987030
19.

Multiple endocrine neoplasia type 2: evaluation of the genotype-phenotype relationship.

Yip L, Cote GJ, Shapiro SE, Ayers GD, Herzog CE, Sellin RV, Sherman SI, Gagel RF, Lee JE, Evans DB.

Arch Surg. 2003 Apr;138(4):409-16; discussion 416.

PMID:
12686527
20.

Novel tandem germline RET proto-oncogene mutations in a patient with multiple endocrine neoplasia type 2B: report of a case and a literature review of tandem RET mutations with in silico analysis.

Nakao KT, Usui T, Ikeda M, Mori Y, Yamamoto T, Kawashima ST, Nanba K, Yuno A, Tamanaha T, Tagami T, Naruse M, Asato R, Shimatsu A.

Head Neck. 2013 Dec;35(12):E363-8. doi: 10.1002/hed.23241. Epub 2013 Mar 6. Review.

PMID:
23468374

Supplemental Content

Support Center